DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, today announced the peer-reviewed ...

Researchers identify a new player in human immunity that can go rogue and turn the immune system against the body’s own ...

A common artificial sweetener may trigger insulin spikes that lead to the build up of fatty plaques in the arteries, ...